missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Human Versican V0, V1 Neo (aa 436-441) Synthetic Peptide

Numéro de catalogue. PEP235
Modifier l'affichage
Click to view available options
Quantité:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Numéro de catalogue. Quantité
PEP235 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Numéro de catalogue. PEP235 Fournisseur Invitrogen™ Code fournisseur PEP235
Saison des économies
Afficher toutes les promotions

Pour de l'aide SVP utiliser la function de clavardage; nous envoyer un couriel à help@thermofisher.com ou appelez le service à la clientèle au 1-800-234-7437.

Synthetic Peptide

PEP-235 is a 9 amino acid synthetic peptide corresponding to amino acid residues 436-441 from human Versican. The sequence of this peptide is (amino to carboxy terminus): C G G D (436) P E A A E (441). This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product, catalog # PA1-1748A. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (~70-fold) for competitive inhibition of antibody-protein binding reactions. Reconstitute with 0.1 mL of distilled water.

Versican is a member of the family of large aggregating proteoglycans (also including aggrecan, brevican, and neurocan). The protein shows wide tissue distribution which includes fibrous, articular, and elastic cartilages, as well as nervous, epidermal, arterial, and loose connective tissues. Versican V1 has been shown to enhance cell proliferation, and also induce cell transformation and protect cells from apoptosis. This was demonstrated through its ability to downregulate the expression of proapoptotic Bad. Versican's existence as a extracellular matrix protein in human airways has also lead to the discovery of an inflammatory role in asthmatics.

Spécifications

ID du gène (Entrez) 1462
Espèces Human
Méthode de purification purified
Numéro d'enregistrement P13611
Nom usuel Versican
Concentration 0.5 mg/mL
Contenu et stockage -20°C. Avoid freeze-thaw cycles.
Aperçu général Synthetic Peptide
Format Lyophilized
Formule Peptide with no preservative
À utiliser avec (application) Control
Alias du gène 5430420N07Rik; 9430051N09; Chondroitin sulfate proteoglycan 2; chondroitin sulfate proteoglycan 2 (versican); chondroitin sulfate proteoglycan core protein 2; Cspg2; DPEAAE; ERVR; GHAP; glial hyaluronate-binding protein; hdf; heart defect; large fibroblast proteoglycan; NG2; PGM; PG-M; PG-M core protein; PG-M(V0); PG-M(V1); V1 Neo; VCAN; versican; versican core protein; Versican core protein precursor (Large fibroblast proteoglycan) (Chondroitin sulfate proteoglycan core protein 2) (PG-M); versican proteoglycan; Versican V0; WGN; WGN 1; WGN1
Symbole de gène VCAN
Lyophilisé Yes
Conservateur No preservative
Type de produit Peptide
Quantité 50 μg
Statut réglementaire RUO
Séquence C G G D(436) P E A A E(441)
Afficher plus de résultats Afficher moins de résultats